NASDAQ·US·Drug Manufacturers - General
BMYBMY
0คะแนน
สรุป
เสี่ยง
ความมั่นใจ 89%
$57.59—
Today's session
Upside?
+50.0%
FV $113.04
P/E (TTM)?
16.6
Earnings yield
FCF yield?
9.5%
Mcap $117.58B
ถือ
Fundamental buy·Technical neutral
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strongly positive
4 · 2 · 1
Strengths
- Pristine fundamentals (Piotroski 7+)9/9
- Trading well below consensus fair value50%
- High FCF yield9%
- ROIC well above cost of capital — value-creating13%
Risks
- Inconsistent profitability3/10
Watchlist
- Gross margins under pressure
- Long-term debt rising — monitor leverage
$57.59+22.9%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
5 of 5 models · trimmed-mean consensus
Consensus FV
$113.04
Upside
+50.0%
Now $57.59
Our FV$113.04
Price$57.59
$10.12$368.76
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$117.58B
P/E (TTM)?
16.6
FCF yield?
9.5%
Dividend
$2.49
4.3% yield
52w range
$41.67 – $61.73
Score confidence
89%
Data completeness
Last updated 4/30/2026, 5:19:52 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer